Prebiopsy Multiparametric Magnetic Resonance Imaging for Prostate Cancer Diagnosis in Biopsy-naive Men with Suspected Prostate Cancer Based on Elevated Prostate-specific Antigen Values: Results from a Randomized Prospective Blinded Controlled Trial.
暂无分享,去创建一个
Saila Kauppila | Eveliina Lammentausta | M. Vaarala | P. Ohtonen | E. Pääkkö | S. Kauppila | E. Lammentausta | Pasi Ohtonen | Eija Pääkkö | Markku H Vaarala | Panu P Tonttila | Juha Lantto | Ulla Piippo | P. Tonttila | Juha Lantto | U. Piippo
[1] P. Pinto,et al. Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion‐guided biopsy increase the detection of anteriorly located prostate cancers , 2014, BJU international.
[2] Yousef Mazaheri,et al. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. , 2011, Radiology.
[3] Pierre Mozer,et al. Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review. , 2015, European urology.
[4] U. Capitanio,et al. Testing the most stringent criteria for selection of candidates for active surveillance in patients with low‐risk prostate cancer , 2010, BJU International.
[5] M Bolla,et al. EAU guidelines on prostate cancer. , 2001, European urology.
[6] B. Carey,et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.
[7] Zeike A. Taylor,et al. MR to ultrasound registration for image-guided prostate interventions , 2012, Medical Image Anal..
[8] Naira Muradyan,et al. Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. , 2013, The Journal of urology.
[9] G. Haber,et al. Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.
[10] A W Partin,et al. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. , 1998, JAMA.
[11] T. H. van der Kwast,et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. , 2014, European urology.
[12] William J Catalona,et al. Serial biopsy results in prostate cancer screening study. , 2002, The Journal of urology.
[13] Thomas Hambrock,et al. Simulated required accuracy of image registration tools for targeting high-grade cancer components with prostate biopsies , 2013, European Radiology.
[14] Xavier Leroy,et al. Dynamic contrast-enhanced-magnetic resonance imaging evaluation of intraprostatic prostate cancer: correlation with radical prostatectomy specimens. , 2009, Urology.
[15] M. Terris,et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. , 1989, The Journal of urology.
[16] H. Ozen,et al. An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer. , 2004, European urology.
[17] J. Fütterer,et al. Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.
[18] J. Fütterer,et al. Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.
[19] P. Choyke,et al. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. , 2013, The Journal of urology.
[20] Ashutosh Kumar Singh,et al. Magnetic resonance imaging‐directed transrectal ultrasonography‐guided biopsies in patients at risk of prostate cancer , 2007, BJU international.
[21] Thomas Hambrock,et al. Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers. , 2012, European urology.
[22] D. Nieboer,et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. , 2015, European urology.
[23] D. Dearnaley,et al. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance. , 2009, European urology.
[24] Thomas Hambrock,et al. Prostate cancer: multiparametric MR imaging for detection, localization, and staging. , 2011, Radiology.
[25] Xavier Leroy,et al. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. , 2013, Radiology.
[26] M. Stifelman,et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.
[27] Baris Turkbey,et al. Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla , 2012, BJU international.
[28] P. Carroll,et al. Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging. , 2010, Radiology.
[29] Neil Fleshner,et al. Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study. , 2012, The Journal of urology.
[30] F. Schröder,et al. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.
[31] P. Carroll,et al. Pathological outcomes of candidates for active surveillance of prostate cancer. , 2009, The Journal of urology.